Utilization of the TAD Device for Dispensing Pain Medications in Hospice Patients
NCT ID: NCT03940534
Last Updated: 2019-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
8 participants
INTERVENTIONAL
2018-03-09
2019-02-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Use of a Digital Application for Reporting Pain and Pain Management in Home Hospice
NCT04869085
A Randomized Study of the Efficacy of a New Intervention for Medication Adherence in Chronic Illness: Medications, Meaning and Me (The 3-M Study)
NCT02258516
The Influence of a Medication Adherence Smartphone Application on Medication Adherence in Chronic Illness
NCT05098743
Adherence in Clinical Trials-Induction Strategies
NCT00005453
Increasing Adherence to Treatment Recommendations Following a Cardiac Event
NCT02327260
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Start with Mobile Device
TAD
TAD is a device used to aid medication adherence.
Start without Mobile Device
TAD
TAD is a device used to aid medication adherence.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TAD
TAD is a device used to aid medication adherence.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* inability to demonstrate competent use of the device
* age less than 18
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Intent Solutions, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christopher E Richter, PharmD
Role: PRINCIPAL_INVESTIGATOR
Clinical Pharmacist
Ellen Talos, MD
Role: STUDY_DIRECTOR
Medical Director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haven: Advanced Illness Care
Gainesville, Florida, United States
Haven: Advanced Illness Care
Lake City, Florida, United States
Haven: Advanced Illness Care
Palatka, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
6195-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.